Volume 01 | July 2020
DIALOGUE
Connecting the
Diabetes, Obesity, Metabolism and Complications Community
at Michigan

Welcome to the July 2020 issue of Dialogue!  

MDiabetes is now the Elizabeth Weiser Caswell Diabetes Institute
The   Elizabeth Weiser Caswell Diabetes Institute   supplants the Michigan Diabetes Center (MDiabetes), and will continue to be led by Director Martin G. Myers, Jr., M.D., Ph.D. and Managing Director, Dorene S. Markel, M.S., M.H.S.A. Learn more about the gift that establishes the new institute  here .

If you have news items or events of interest to the diabetes, obesity, metabolism and complications community at Michigan, please tell us. Also, we welcome all input and suggestions -- let us know what you think we should be doing. Email us at  MichiganDiabetes@med.umich.edu  or call 734-764-4433.
Steno North American Fellowships is a transatlantic collaboration in clinical and health outcomes diabetes-related research, enhancing the synergies between the institutions for the benefit of people suffering from diabetes.

The partner institutions are Joslin Diabetes Center, University of Toronto, University of Michigan and the Steno Diabetes Centers in Denmark:  Steno Diabetes Centre North Jutland Steno Diabetes Center Aarhus Steno Diabetes Center Odense Steno Diabetes Center Zealand  or  Steno Diabetes Center Copenhagen .

The fellowship offers researchers, affiliated with one of the partnering institutions, the opportunity to dedicate from 3 months to 1.5 years to practice clinical and health outcomes diabetes-related research at one of the other transatlantic partner institutions mentioned above.

Preventing Early Renal Loss in Diabetes (PERL) Study Published in the New England Journal of Medicine ( NEJM )
Promising treatment to slow kidney disease doesn’t prove out in clinical trial

Scientists find that reducing levels of uric acid in the blood does not guard against complication in patients with type 1 diabetes.
 
Historically, half or more of people with type 1 diabetes develop kidney disease, which frequently progresses to kidney failure requiring hemodialysis or a kidney transplant for survival. This high rate of this diabetic complication has dropped slightly in recent years, with the advent of better ways to control blood glucose (sugar) levels and better blood pressure control, including blood pressure drugs that block the renin-angiotensin system, “but diabetic kidney disease remains a huge problem,” says Rodica Pop-Busui, MD, PhD.

Recognition
Terrance Wong, MD
 MDiabetes COVID-19 and Metabolic Disease Grant Program Award
The ongoing COVID-19 pandemic poses an enormous number of challenges, many of them disproportionately affecting those with diabetes, obesity, and related conditions. To understand and begin to alleviate the impact of COVID-19 on those with diabetes and related disorders, the MDiabetes COVID-19 and Metabolic Disease Grant Program was established to address the impact of COVID-19 on and improve the care of those with diabetes and related disorders.

Congratulations to Dr. Terrance Wong, whose proposal entitled “ Impact of Clonal Hematopoiesis on COVID-19 Morbidity and Mortality ” was selected for funding. Dr. Wong’s research focuses on understanding how alterations in the immune system defined by clonal hematopoiesis contribute to the cytokine storm and poor prognosis of people with diabetes and metabolic syndrome during COVID-19.
In The News
A Wife and Mother Turned Diabetes Research Crusader

When Elizabeth Weiser Caswell had two of three sons diagnosed with type 1 diabetes, she became relentless in her pursuit of more diabetes research, education and a cure. Now, her family is giving a $30 million gift to U-M in her honor.

Events
For a full list of events go to the Elizabeth Weiser Caswell Diabetes Institute Calendar of Events
 Email us to subscribe to our weekly Event Roundup email
Funding Opportunities
Michigan Diabetes Research Center 2020-21 Regional Pilot/Feasibility Grant Program
Deadline: August 5, 2020
Michigan Diabetes Research Center 2020-21 Pilot/Feasibility Grant Program
Deadline: August 5, 2020
Michigan Diabetes Research Center 2020-21 Diabetes Interdisciplinary Study Program
Deadline: August 5, 2020
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship
For additional funding opportunities visit the Elizabeth Weiser Caswell Diabetes Institute Funding Opportunities
Visit the Michigan Medical School Competition Space for more funding opportunities at the Medical School
About the Elizabeth Weiser Caswell Diabetes Institute

The University of Michigan has outstanding clinicians and researchers in diabetes, metabolic disorders, and their complications. The Elizabeth Weiser Caswell Diabetes Institute serves as the central hub to coordinate these programs. We work across disciplines and serve to integrate rigorous science with patient-centered clinical care to prevent, treat, and ultimately cure diabetes and related disorders.
Contact Us
Elizabeth Weiser Caswell Diabetes Institute
300 North Ingalls Building, Room 1135
Ann Arbor, Michigan 48109-5405

734-764-4433




Stay Informed
Did you receive this newsletter from a friend?

Email us at 
to be added to our mailing list.
Supporting the Elizabeth Weiser Caswell Diabetes Institute
Gifts to t he Elizabeth Weiser Caswell Diabetes Institute are essential to our mission, to be at the forefront of cutting-edge research and to educate the next generation of leaders to be the best in medicine. Please consider supporting t he Elizabeth Weiser Caswell Diabetes Institute : gifts can be made through multiple vehicles such as cash or securities, pledges, payroll deduct, etc. Our development partner, Andrea LaFave is happy to discuss and explore different options with you.

Please feel free to reach out to Andrea at (734) 763-6173 or at ajlafave@umich.edu .